EGFR and intrahepatic cholangiocarcinoma: Silencing of FX and SLC35C1 inhibits Notch and EGFR/nuclear factor kappa B (NF-κB) signaling, thereby suppressing the growth and migration of intrahepatic cholangiocarcinoma cells.